← Health Catalyst, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $28.4m | $18.0m | $92.0m | $193.2m | $116.3m | $106.3m | $249.6m | $50.8m | |
| Short-term investments | $4.8m | $210.2m | $178.9m | $251.8m | $247.2m | $211.5m | $142.4m | $44.9m | |
| Accounts receivable, net | $27.7m | $27.6m | $48.3m | $48.8m | $48.0m | $60.3m | $57.2m | $59.1m | |
| Prepaid expenses and other assets | $5.3m | $7.5m | $10.6m | $14.6m | $16.3m | $15.4m | $16.5m | $14.4m | |
| Total current assets | $66.9m | $264.2m | $329.8m | $508.4m | $427.8m | $393.4m | $465.6m | $169.3m | |
| Property and equipment, net | $4.7m | $4.3m | $12.9m | $23.3m | $25.9m | $25.7m | $29.4m | $33.8m | |
| Intangible assets, net | $28.3m | $25.5m | $98.9m | $104.8m | $92.2m | $73.4m | $86.1m | $77.7m | |
| Goodwill | $3.7m | $3.7m | $107.8m | $170.0m | $186.0m | $190.7m | $259.8m | $209.1m | |
| Operating lease right-of-use assets | $6.3m | $3.8m | $24.7m | $21.1m | $16.7m | $13.9m | $12.1m | $6.6m | |
| Other assets | $1.1m | $810k | $3.6m | $4.5m | $3.7m | $4.7m | $6.0m | $6.1m | |
| Deferred revenue | $24.8m | $30.7m | $47.1m | $56.6m | $55.0m | $55.8m | $53.3m | $56.1m | |
| Operating lease liabilities | $2.6m | $2.8m | $2.6m | $3.4m | $3.4m | $3.4m | $3.6m | $3.8m | |
| Operating lease liabilities, net of current portion | $4.2m | $1.7m | $23.7m | $20.2m | $18.0m | $17.7m | $16.3m | $14.2m | |
| Contingent consideration liabilities, net of current portion | $3.8m | $1.9m | $16.8m | $14.7m | $0 | — | $0 | $250k | |
| Other liabilities | $0 | $326k | $2.2m | $113k | $121k | $74k | $154k | $798k | |
| Total stockholders’ equity | ($374.8m) | $200.6m | $276.1m | $522.1m | $425.0m | $366.9m | $365.2m | $245.8m | |
| Total assets | $111.0m | $302.4m | $577.7m | $832.1m | $752.3m | $701.8m | $858.9m | $502.6m | |
| Total liabilities and stockholders’ equity | $111.0m | $302.4m | $577.7m | $832.1m | $752.3m | $701.8m | $858.9m | $502.6m | |
| Accounts payable | $1.8m | $3.6m | $5.3m | $4.7m | $4.4m | $6.6m | $11.4m | $9.4m | |
| Accrued liabilities | $9.2m | $8.9m | $16.5m | $23.7m | $19.7m | $23.3m | $26.3m | $18.7m | |
| Current portion of long-term debt | $1.3m | $0 | — | — | — | $0 | $231.2m | $1.6m | |
| Long-term debt, net of current portion | $18.8m | $48.2m | $169.0m | $180.9m | $226.5m | $228.0m | $151.2m | $151.6m | |
| Deferred revenue, net of current portion | $7.3m | $1.5m | $1.9m | $929k | $105k | $77k | $249k | $410k | |
| Total current liabilities | $41.8m | $48.2m | $88.0m | $93.1m | $82.5m | $89.0m | $325.9m | $89.6m | |
| Total liabilities | $75.9m | $101.7m | $301.6m | $310.0m | $327.3m | $334.9m | $493.7m | $256.9m | |
| Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and 2024 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.001 par value per share, and additional paid-in capital; 500,000,000 shares authorized as of December 31, 2025 and 2024; 72,027,332 and 64,043,799 shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | 0 | 0 | 1.4b | 1.4b | 1.5b | 1.6b | 1.6b | |
| Accumulated deficit | ($374.8m) | ($610.5m) | ($725.6m) | ($878.9m) | ($999.0m) | ($1.1b) | ($1.2b) | ($1.4b) | |
| Accumulated other comprehensive income (loss) | ($1k) | $72k | $61k | ($67k) | ($648k) | $33k | ($835k) | $1.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.